Publicacións (220) Publicacións de Antonio Monge Vega

2021

  1. Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors

    Acta Pharmaceutica, Vol. 71, Núm. 3, pp. 485-495

2020

  1. In vitro and in vivo evaluation of quinoxaline 1,4-di-n-oxide against giardia lamblia

    Letters in Drug Design and Discovery, Vol. 17, Núm. 4, pp. 426-431

2018

  1. Anti-mycobacterium tuberculosis activity of esters of quinoxaline 1,4-Di-N-oxide

    Molecules, Vol. 23, Núm. 6

  2. Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana

    Parasitology Research, Vol. 117, Núm. 1, pp. 45-58

2017

  1. Trypanocidal activity of quinoxaline 1,4 Di-N-oxide derivatives as trypanothione reductase inhibitors

    Molecules, Vol. 22, Núm. 2

2016

  1. Ester of quinoxaline-7-carboxylate 1,4-di-N-oxide as apoptosis inductors in K-562 cell line: An in vitro, QSAR and DFT study

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 16, pp. 682-691

2014

  1. Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives

    Parasitology Research, Vol. 113, Núm. 6, pp. 2027-2035

  2. Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents

    Molecules, Vol. 19, Núm. 2, pp. 2166-2180

2013

  1. Cyclic voltammetric study of some anti-chagas-active 1,4-dioxidoquinoxalin- 2-yl ketone derivatives

    Helvetica Chimica Acta, Vol. 96, Núm. 2, pp. 217-227

  2. New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities

    Molecules, Vol. 18, Núm. 4, pp. 4718-4727

  3. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents

    European Journal of Medicinal Chemistry, Vol. 66, pp. 324-334

  4. Pharmaceutical innovation: A university experience

    Revista Virtual de Quimica, Vol. 5, Núm. 6, pp. 1052-1058

  5. Phenazine N,N′-dioxide scaffold as selective hypoxic cytotoxin pharmacophore. Structural modifications looking for further DNA topoisomerase II-inhibition activity

    MedChemComm, Vol. 4, Núm. 3, pp. 595-607

  6. Quinoxalinas como potenciales agentes Antimycobacterium tuberculosis: una revisión

    Revista de la Sociedad Química del Perú, Vol. 79, Núm. 3, pp. 272-285

  7. Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 15, pp. 4550-4558

2012

  1. Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4- phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives

    Molecules, Vol. 17, Núm. 8, pp. 9451-9461

  2. New quinoxaline derivatives as potential mt1 and mt2 receptor ligands

    Molecules, Vol. 17, Núm. 7, pp. 7737-7757

  3. Novel sulfonylurea derivatives as H 3 receptor antagonists. Preliminary SAR studies

    European Journal of Medicinal Chemistry, Vol. 52, pp. 1-13

2011

  1. 1,4-Di-N-oxide quinoxaline-2-carboxamide: Cyclic voltammetry and relationship between electrochemical behavior, structure and anti-tuberculosis activity

    Electrochimica Acta, Vol. 56, Núm. 9, pp. 3270-3275

  2. 3-trifluoromethylquinoxaline N, N′-dioxides as anti-Trypanosomatid agents. Identification of optimal anti- T. cruzi agents and mechanism of action studies

    Journal of Medicinal Chemistry, Vol. 54, Núm. 10, pp. 3624-3636